ALKEM

Alkem Laboratories Share Price

₹5,427.50 -66.75 (-1.21%)

21 Dec, 2024 19:52

SIP TrendupStart SIP in ALKEM

Start SIP

Performance

  • Low
  • ₹5,405
  • High
  • ₹5,543
  • 52 Week Low
  • ₹4,407
  • 52 Week High
  • ₹6,440
  • Open Price₹5,535
  • Previous Close₹5,494
  • Volume113,105

Investment Returns

  • Over 1 Month -1.85%
  • Over 3 Month -10.83%
  • Over 6 Month + 5.22%
  • Over 1 Year + 11.28%
SIP Lightning

Smart Investing Starts Here Start SIP with Alkem Laboratories for Steady Growth!

Invest Now

Alkem Laboratories Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.

  • P/E Ratio
  • 30.6
  • PEG Ratio
  • 0.6
  • Market Cap Cr
  • 64,894
  • P/B Ratio
  • 6.1
  • Average True Range
  • 135.57
  • EPS
  • 181.86
  • Dividend Yield
  • 0.7
  • MACD Signal
  • -78.7
  • RSI
  • 41.78
  • MFI
  • 33.51

Alkem Laboratories Financials

Alkem Laboratories Technicals

EMA & SMA

Current Price
₹5,427.50
-66.75 (-1.21%)
pointer
  • stock-down_img
  • Bullish Moving Average 0
  • stock-up_img
  • Bearish Moving Average 16
  • 20 Day
  • ₹5,514.40
  • 50 Day
  • ₹5,648.07
  • 100 Day
  • ₹5,656.91
  • 200 Day
  • ₹5,428.40

Resistance and Support

5458.52 Pivot Speed
  • R3 5,650.68
  • R2 5,596.97
  • R1 5,512.23
  • S1 5,373.78
  • S2 5,320.07
  • S3 5,235.33

What's your outlook on Alkem Laboratories?

You can only vote for once

Ratings

Master Rating

EPS Strenth

Price Strength

Buyer Demand

Group Rank

Alkem Laboratories Ltd, is one of India’s largest pharmaceutical companies, known for its leading brands like Clavam and Pan-D. With 21 manufacturing facilities and global presence in over 50 countries, Alkem drives innovation with 500+ scientists across 5 R&D centers.

Alkem Laboratories has an operating revenue of Rs. 12,706.18 Cr. on a trailing 12-month basis. An annual revenue growth of 10% is good, Pre-tax margin of 16% is great, ROE of 17% is exceptional. The company is debt free and has a strong balance sheet enabling it to report stable earnings growth across business cycles. The stock from a technical standpoint is trading below to its 50DMA and close to its 200DMA. It needs to take out the 50DMA levels and stay above it to make any further meaningful move. From an O'Neil Methodology perspective, the stock has an EPS Rank of 70 which is a FAIR score but needs to improve its earnings, a RS Rating of 36 which is POOR indicating the underperformance as compared to other stocks, Buyer Demand at C+ which is evident from recent supply seen, Group Rank of 50 indicates it belongs to a fair industry group of Medical-Diversified and a Master Score of C is fair but needs to improve. Institutional holding has gone up in the last reported quarter is a positive sign. Overall, the stock has mediocre earnings and technical strength, there are superior stocks in the current market environment.

Disclaimer: This stock analysis report is algorithmically generated for informational purposes only and should not be considered as a buy or sell recommendation.

View More

Alkem Laboratories Corporate Actions - Bonus, Splits, Dividends

Date Purpose Remarks
2024-11-13 Quarterly Results
2024-08-09 Quarterly Results
2024-05-29 Audited Results & Final Dividend
2024-02-09 Quarterly Results & Interim Dividend
2023-11-07 Quarterly Results
Date Purpose Remarks
2024-08-10 FINAL Rs.5.00 per share(250%)Final Dividend
2024-02-17 INTERIM Rs.35.00 per share(1750%)Interim Dividend
2023-08-10 FINAL Rs.10.00 per share(500%)Final Dividend
2023-02-18 INTERIM Rs.15.00 per share(750%)Interim Dividend
2023-02-18 SPECIAL Rs.25.00 per share(1250%)Special Dividend

Alkem Laboratories F&O

Alkem Laboratories Shareholding Pattern

55.66%
14.94%
3.18%
9.02%
0%
15.85%
1.35%

About Alkem Laboratories

  • NSE Symbol
  • ALKEM
  • BSE Symbol
  • 539523
  • Managing Director
  • Mr. Sandeep Singh
  • ISIN
  • INE540L01014

Similar Stocks to Alkem Laboratories

Alkem Laboratories FAQs

Alkem Laboratories share price is ₹5,427 As on 21 December, 2024 | 19:38

The Market Cap of Alkem Laboratories is ₹64893.9 Cr As on 21 December, 2024 | 19:38

The P/E ratio of Alkem Laboratories is 30.6 As on 21 December, 2024 | 19:38

The PB ratio of Alkem Laboratories is 6.1 As on 21 December, 2024 | 19:38

Open Free Demat Account

Be a part of 5paisa community - The first listed discount broker of India.

+91

By proceeding, you agree to all T&C*

footer_form

Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.

Q2FY23